Bree B. Aldridge

Also affiliated with Harvard University, CNR de la Résistance aux Antibiotiques, Center for Systems Biology

MedicineBiochemistry, Genetics and Molecular BiologyComputer Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 26 papers. Top paper: “Identification of cell wall synthesis inhibitors active against Mycobacterium tuberculosis by competitive activity-based protein profiling”.

Identification of cell wall synthesis inhibitors active against Mycobacterium tuberculosis by competitive activity-based protein profiling

Cell chemical biology(2021)10.1016/j.chembiol.2021.09.002

N/A

0.557DataRank · unranked

40 citations

Hiren V. Patel, Armand B. Cognetta, Trever C. Smith, Ivy Mallick, Jean‐François Cavalier +6 more

Single-cell imaging of the Mycobacterium tuberculosis cell cycle reveals linear and heterogenous growth

Nature Microbiology(2024)10.1038/s41564-024-01846-z

N/A

0.477DataRank · unranked

23 citations

Prathitha Kar, Maliwan Kamkaew, Ariel Amir, Bree B. Aldridge, Eun Seon Chung

Novel Synergies and Isolate Specificities in the Drug Interaction Landscape of Mycobacterium abscessus

Antimicrobial Agents and Chemotherapy(2023)10.1128/aac.00090-23

N/A

0.470DataRank · unranked

22 citations

Yonatan N. Degefu, Pathricia A. Leus, Jonah Larkins‐Ford, Jacob A. Klickstein, Florian P. Maurer +6 more

Critical role of growth medium for detecting drug interactions in Gram-negative bacteria that model in vivo responses

mBio(2024)10.1128/mbio.00159-24

N/A

0.373DataRank · unranked

11 citations

Yoelkys Morales, Rachel Ende, Ryan Peters, Anne L. McCabe, Joan Mecsas +2 more

Predicting tuberculosis drug efficacy in preclinical and clinical models from in vitro data

iScience(2025)10.1016/j.isci.2025.111932

N/A

0.241DataRank · unranked

4 citations

Anu Patel, Bernard Ngara, Rob C. van Wijk, Natasha Strydom, Qianwen Wang +9 more

Integration of multi-modal measurements identifies critical mechanisms of tuberculosis drug action

Cell Systems(2025)10.1016/j.cels.2025.101348

N/A

0.208DataRank · unranked

3 citations

A. Paul Alivisatos, Trever C. Smith, Nhi Van, Vijay Soni, Joshua B. Wallach +10 more

Multiscale Model Identifies Improved Schedule for Treatment of Acute Myeloid Leukemia In Vitro With the Mcl‐1 Inhibitor AZD5991

CPT Pharmacometrics & Systems Pharmacology(2020)10.1002/psp4.12552

N/A

0.208DataRank · unranked

3 citations

Haley Woods, Adriana E. Tron, Matthew A. Belmonte, J. Paul Secrist, Douglas Ferguson +5 more

Morphological profiling of tubercule bacilli identifies drug pathways of action

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.03.11.987545

N/A

0.165DataRank · unranked

2 citations

Krista M. Pullen, Michaela C. Olson, Morgan E. McNellis, Ian Richardson, Sophia Hu +6 more

Localization of EccA3 at the growing pole in Mycobacterium smegmatis

BMC Microbiology(2022)10.1186/s12866-022-02554-6

N/A

0DataRank · unranked

7 citations

Mae Newton-Foot, Owen T. Bennion, Bree B. Aldridge, Carolina Mehaffy, John T. Belisle +5 more

Tuberculosis treatment failure associated with evolution of antibiotic resilience

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.03.29.486233

N/A

0DataRank · unranked

14 citations

Junhao Zhu, Charles L. Dulberger, Sydney Stanley, Sean Wilson, Eun Seon Chung +12 more

Critical role of growth medium for detecting drug interactions in Gram-negative bacteria that model in vivo responses

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.09.20.508761

N/A

0DataRank · unranked

1 citations

Yoelkys Morales, Anne L. McCabe, Joan Mecsas, Bree B. Aldridge, Kathleen P. Davis

Novel synergies and isolate specificities in the drug interactions landscape of Mycobacterium abscessus

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.12.12.520102

N/A

0DataRank · unranked

1 citations

Yonatan N. Degefu, Pathricia A. Leus, Jonah Larkins‐Ford, Jacob A. Klickstein, Florian P. Maurer +6 more

Tools to develop antibiotic combinations that target drug tolerance in Mycobacterium tuberculosis

Frontiers in Cellular and Infection Microbiology(2023)10.3389/fcimb.2022.1085946

N/A

0DataRank · unranked

13 citations

Bree B. Aldridge, Talia Greenstein

Mycobacterium tuberculosis grows linearly at the single-cell level with larger variability than model organisms

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.05.17.541183

N/A

0DataRank · unranked

6 citations

Prathitha Kar, Maliwan Kamkaew, Ariel Amir, Bree B. Aldridge, Eun Seon Chung

Semi-automated colony-forming unit counting for biosafety level 3 laboratories

STAR Protocols(2023)10.1016/j.xpro.2023.102442

N/A

0DataRank · unranked

0 citations

Sophie Engels, Pariksheet Nanda, Maral Budak, Talia Greenstein, Mariana Pereira Moraes +3 more

In vitro identification of underutilized β-lactam combinations against methicillin-resistant Staphylococcus aureus bacteremia isolates

Microbiology Spectrum(2024)10.1128/spectrum.00976-24

N/A

0DataRank · unranked

5 citations

L. A. McDermott, David R. Snydman, Bree B. Aldridge, Kathleen P. Davis

Massively parallel combination screen reveals small molecule sensitization of antibiotic-resistant Gram-negative ESKAPE pathogens

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.03.26.586803

N/A

0DataRank · unranked

1 citations

Meilin Zhu, Benjamin Peters, Efrat Hamami, Julie Chen, Kathleen P. Davis +18 more

GEODE: an in silico tool that translates in vitro to in vivo predictions of tuberculosis antibiotic combination efficacy

Frontiers in Pharmacology(2025)10.3389/fphar.2025.1639673

N/A

0DataRank · unranked

1 citations

Mariana Pereira Moraes, Talia Greenstein, Pauline Maiello, H. Jacob Borish, Harris B. Chishti +8 more

Increased proportion of growth-arrested bacilli in acidic pH adaptation promotes Mycobacterium tuberculosis treatment survival

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.07.14.664820

N/A

0DataRank · unranked

0 citations

William Johnson, Maliwan Kamkaew, Morgan E. McNellis, Trever C. Smith, Srinivasan Vijay +4 more

Systematic measurement of combination-drug landscapes to predict in vivo treatment outcomes for tuberculosis

Cell Systems(2021)10.1016/j.cels.2021.08.004

N/A

0DataRank · unranked

81 citations

Talia Greenstein, Nhi Van, Yonatan N. Degefu, Michaela C. Olson, Artem Sokolov +2 more

The Tuberculosis Drug Accelerator at year 10: what have we learned?

Nature Medicine(2021)10.1038/s41591-021-01442-2

N/A

0DataRank · unranked

62 citations

David Barros-Aguirre, Clifton E. Barry, Robert H. Bates, Steven J. Berthel, Helena I. Boshoff +32 more

Pharmacokinetics and Target Attainment of SQ109 in Plasma and Human-Like Tuberculosis Lesions in Rabbits

Antimicrobial Agents and Chemotherapy(2021)10.1128/aac.00024-21

N/A

0DataRank · unranked

25 citations

Jansy P. Sarathy, Kamunkhwala Gausi, Matthew Zimmerman, Han Wang, Gert-Jan Wijnant +10 more

Systematic measurement of combination drug landscapes to predict in vivo treatment outcomes for tuberculosis

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.02.03.429579

N/A

0DataRank · unranked

5 citations

Talia Greenstein, Nhi Van, Yonatan N. Degefu, Michaela C. Olson, Artem Sokolov +2 more

Design principles to assemble drug combinations for effective tuberculosis therapy using interpretable pairwise drug response measurements

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.12.05.471248

N/A

0DataRank · unranked

5 citations

Yonatan N. Degefu, Nhi Van, Artem Sokolov, Bree B. Aldridge, Jonah Larkins‐Ford

Design principles to assemble drug combinations for effective tuberculosis therapy using interpretable pairwise drug response measurements

Cell Reports Medicine(2022)10.1016/j.xcrm.2022.100737

N/A

0DataRank · unranked

47 citations

Yonatan N. Degefu, Nhi Van, Artem Sokolov, Bree B. Aldridge, Jonah Larkins‐Ford

Advances in the design of combination therapies for the treatment of tuberculosis

Expert Opinion on Drug Discovery(2022)10.1080/17460441.2023.2157811

N/A

0DataRank · unranked

45 citations

Bree B. Aldridge, Jonah Larkins‐Ford